Use of beta-interferon in the treatment of multiple sclerosis: high-rate injectable dose therapy
Demina, T.L.; Khachanova, N.V.; Davydovskaia, M.V.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 105(5): 76-79
2005
ISSN/ISBN: 1997-7298 PMID: 15952547 Document Number: 589219
Document emailed within 1 workday
Related Documents
Wilson, B.A. 1995: Interferon beta for treatment of multiple sclerosis Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 4(2): 151-153Cardy, P. 1997: Interferon beta in multiple sclerosis. Relapses deserve treatment Bmj 314(7080): 602
Khabirov, F.A.; Babicheva, N.N.; Khaĭbullin, T.I.; Aver'ianova, L.A.; Granatov, E.V.; Akhmedova, G.M. 2012: Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(9 Part 2): 113-122
De Haan, R.J.; Polman, C.H. 1996: Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis Nederlands Tijdschrift Voor Geneeskunde 140(44): 2168-2171
Bencsik, K.; Rajda, C.; Klivényi, P.; Járdánházy, T.; Török, M.; Vécsei, L. 1999: Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b Orvosi Hetilap 140(14): 763-766
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Lebrun, C. 2001: Beta-interferon clinical trials using MRI in patients with multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 761-767
Schwab, W.; Ries, G.; Handschuh, K. 1986: Initial experiences with interstitial brachycurietherapy (low dose rate I-125 seeds in carrier/vicryl and high dose rate Ir-192 afterloading system) in the palliative treatment of head and neck tumors Hno 34(8): 327-333
Bartholomé, E.J.; Willems, F.; Crusiaux, A.; Thielemans, K.; Schandené, L.; Goldman, M. 1999: Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis Acta Neurologica Belgica 99(1): 44-52
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Burnfield, A. 1997: Interferon beta in multiple sclerosis. Reducing frequency and severity of relapses will be of great clinical benefit Bmj 314(7080): 600
Nomura, M.; Suzumura, A.; Anno, H.; Miyata, E.; Koga, S.; Yamamoto, H. 1995: Clinical usefulness of MRi in acute phase of spinal multiple sclerosis--influence of high-dose steroid therapy in acute phase Rinsho Shinkeigaku 35(3): 225-230
Huber, M. 1988: Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results Der Nervenarzt 59(9): 514-520
Kastrukoff, L.F.; Oger, J.J.; Tourtellotte, W.W.; Sacks, S.L.; Berkowitz, J.; Paty, D.W. 1991: Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluation Neurology 41(12): 1936-1941
Carter, J.L.; Hafler, D.A.; Dawson, D.M.; Orav, J.; Weiner, H.L. 1988: Immunosuppression with high-dose I.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients Neurology 38(7 Suppl 2: 9-14
Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up Acta Neurologica 15(1): 33-43
Watanabe, T.; Yamamoto, T.; Saito, T.; Sugano, M.; Tsukamoto, T. 1993: Pulse-dose cyclophosphamide therapy for chronic progressive multiple sclerosis Rinsho Shinkeigaku 33(1): 15-20
Onal, S.; Kazokoglu, H.; Koç, A.; Akman, M.; Bavbek, T.; Direskeneli, H.; Yavuz, S. 2009: Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behçet's uveitis Clinical and Experimental Rheumatology 27(2 Suppl 53: S113-S114
Palao-Duarte, S.; Corral-Corral, I.; Zarza, B.; Costa-Frossard, L. 2005: Ulcerative colitis in a female patient with multiple sclerosis receiving treatment with interferon Revista de Neurologia 41(5): 319-320
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77